Indication
Hepatocellular Carcinoma (HCC)
2 clinical trials
3 products
Clinical trial
Phase I/II Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic TherapyStatus: Active (not recruiting), Estimated PCD: 2024-01-31
Product
NMS-01940153EClinical trial
A Prospective, Randomized, Open-label, Multicenter Study to Evaluate the Peginterferon, Comparing to Nucleos(t)Ide Analogues, in Reducing the Incidence of HCC in Chronic Hepatitis B Patients With Intermediate to High Liver Cancer RisksStatus: Recruiting, Estimated PCD: 2023-08-01
Product
Peginterferon alfa-2bProduct
Nucleos(t)ide analogue